Nanoviricides inc (NNVC) Annual Balance Sheets

Annual · GAAP · USD millions
Access NNVC quarterly Balance Sheets →
This page allows investors to track Nanoviricides inc's balance sheet development across multiple reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Jun 30 2025) (Jun 30 2024) (Jun 30 2023) (Jun 30 2022)
Assets
Cash & cash equivalent2.79
Security Deposit0.00
Cash & Short-term Investments2.00
Prepaid Expense, Current AS0.37
Total Current Assets3.16
Equipment/Property/Plant Net14.70
Intangible Assets0.31
Other Assets, Noncurrent0.00
Service Agreements0.00
Total Assets9.87
Liabilities
Accounts Payable, Current AC0.00
Accrued Liabilities, Current AC0.04
Other Liabilities, Current1.15
Total Current Liabilities1.19
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.01
Total Liabilities1.20
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock165.74
Retained Earnings / Accumulated Deficit-157.06
Other Equity0.00
Common Stockholder's Equity8.68
Preferred Stockholder's Equity0.00
Total Stockholder's Equity8.68
Liabilities & Stockholder's Equity9.87
4 historic quarters locked

Sign in to unlock the full Nanoviricides inc balance sheet history.

About Nanoviricides Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-111390

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.